143
Views
0
CrossRef citations to date
0
Altmetric
Articles

Efficacy of artemether against toxocariasis in mice: parasitological and immunopathological changes in brain, liver, and lung

ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, , ORCID Icon & ORCID Icon show all

References

  • Woodhall DM, Eberhard ML, Parise ME. Neglected parasitic infections in the United States: toxocariasis. Am J Trop Med Hyg. 2014 May;90(5):810–813. doi: 10.4269/ajtmh.13-0725
  • Kuenzli E, Neumayr A, Chaney M, et al. Toxocariasis-associated cardiac diseases–A systematic review of the literature. Acta Trop. 2016 Feb;154:107–120. doi: 10.1016/j.actatropica.2015.11.003
  • El-Shazly AM, Abdel Baset SM, Kamal A, et al. Seroprevalence of human toxocariasis (visceral larva migrans). J Egypt Soc Parasitol. 2009 Dec;39(3):731–744.
  • Elshazly AM, Attia G, El-Ghareeb AS, et al. Clinical varieties of toxocariasis canis in children’s hospital, Mansoura University: is it an underestimated problem? J Egypt Soc Parasitol. 2011 Aug;41(2):263–274.
  • Bayoumy AM, Atallah RB, Mohamed KAA, et al. Seroepidemiological evaluation of toxocariasis in Egyptian children suffering from recurrent urticaria. Egypt J Hosp Med. 2019;76(6):4262–4268.‏. doi: 10.21608/ejhm.2019.43805
  • Gargili A, Demirci C, Kandil A, et al. In vivo inhibition of inducible nitric oxide and evaluation of the brain tissue damage induced by Toxocara canis larvae in experimentally infected mice. Chin J Physiol. 2004 Dec 31;47(4):189–196.
  • Othman AA, Abdel-Aleem GA, Saied EM, et al. Biochemical and immunopathological changes in experimental neurotoxocariasis. Mol Biochem Parasitol. 2010 Jul;172(1):1–8. doi: 10.1016/j.molbiopara.2010.03.006
  • Chou CM, Fan CK. Significant apoptosis rather autophagy predominates in astrocytes caused by Toxocara canis larval excretory-secretory antigens. J Microbiol Immunol Infect. 2020 Apr;53(2):250–258. doi: 10.1016/j.jmii.2018.06.006
  • Chen J, Zhou DH, Nisbet AJ, et al. Advances in molecular identification, taxonomy, genetic variation and diagnosis of Toxocara spp. Infect Genet Evol. 2012 Oct;12(7):1344–1348. doi: 10.1016/j.meegid.2012.04.019
  • Moreira GM, Telmo Pde L, Mendonça M, et al. Human toxocariasis: current advances in diagnostics, treatment, and interventions. Trends Parasitol. 2014 Sep;30(9):456–464. doi: 10.1016/j.pt.2014.07.003
  • Figueiredo SD, Taddei JA, Menezes JJ, et al. Estudo clínico-epidemiológico da toxocaríase em população infantil [Clinical-epidemiological study of toxocariasis in a pediatric population]. J Pediatr (Rio J). 2005 Mar-Apr;81(2):126–132. doi: 10.2223/1317
  • Roldán WH, Espinoza YA, Atúncar A, et al. Frequency of eosinophilia and risk factors and their association with Toxocara infection in schoolchildren during a health survey in the north of Lima, Peru. Rev Inst Med Trop Sao Paulo. 2008 Sep-Oct;50(5):273–278. doi: 10.1590/S0036-46652008000500005
  • Moreira-Silva SF, Rodrigues MG, Pimenta JL, et al. Toxocariasis of the central nervous system: with report of two cases. Rev Soc Bras Med Trop. 2004 Mar-Apr;37(2):169–174. doi: 10.1590/S0037-86822004000200011
  • Eberhardt O, Bialek R, Nägele T, et al. Eosinophilic meningomyelitis in toxocariasis: case report and review of the literature. Clin Neurol Neurosur. 2005 Aug;107(5):432–438. doi: 10.1016/j.clineuro.2004.10.003
  • Fan CK, Holland CV, Loxton K, et al. Cerebral Toxocariasis: Silent Progression to Neurodegenerative Disorders? Clin Microbiol Rev. 2015 Jul;28(3):663–686. doi: 10.1128/CMR.00106-14
  • Sánchez SS, García HH, Nicoletti A. Clinical and magnetic resonance imaging findings of neurotoxocariasis. Front Neurol. 2018 Feb 8;9:53. doi: 10.3389/fneur.2018.00053
  • Janecek E, Waindok P, Bankstahl M, et al. Abnormal neurobehaviour and impaired memory function as a consequence of Toxocara canis- as well as Toxocara cati-induced neurotoxocarosis. PLoS Negl Trop Dis. 2017 May 8;11(5):e0005594. doi: 10.1371/journal.pntd.0005594
  • El–Sayed NM, Ramadan ME. Toxocariasis in children: an update on clinical manifestations, diagnosis, and treatment. J Pediatr Infect Dis. 2017;12(4):222–227.‏. doi: 10.1055/s-0037-1603496
  • Mata-Santos T, Pinto NF, Mata-Santos HA, et al. Anthelmintic Activity Of Lapachol, β-Lapachone And Its Derivatives Against Toxocara canis Larvae. Rev Inst Med Trop Sao Paulo. 2015 May-Jun;57(3):197–204. doi: 10.1590/S0036-46652015000300003
  • Despommier D. Toxocariasis: clinical aspects, epidemiology, medical ecology, and molecular aspects. Clin Microbiol Rev. 2003 Apr;16(2):265–272. doi: 10.1128/CMR.16.2.265-272.2003
  • Daniel-Mwambete K, Torrado S, Cuesta-Bandera C, et al. The effect of solubilization on the oral bioavailability of three benzimidazole carbamate drugs. Int J Pharm. 2004 Mar 19;272(1–2):29–36. doi: 10.1016/j.ijpharm.2003.11.030
  • Rigter IM, Schipper HG, Koopmans RP, et al. Relative bioavailability of three newly developed albendazole formulations: a randomized crossover study with healthy volunteers. Antimicrob Agents Chemother. 2004 Mar;48(3):1051–1054. doi: 10.1128/AAC.48.3.1051-1054.2004
  • Dayan AD. Albendazole, mebendazole and praziquantel. Review of non-clinical toxicity and pharmacokinetics. Acta Trop. 2003 May;86(2–3):141–159. doi: 10.1016/S0001-706X(03)00031-7
  • Musa D, Senocak G, Borazan G, et al. Effects of Nigella sativa and albendazole alone and in combination in Toxocara canis infected mice. J Pak Med Assoc. 2011 Sep;61(9):866–870.
  • Deshayes S, Bonhomme J, de La Blanchardière A. Neurotoxocariasis: a systematic literature review. Infection. 2016 Oct;44(5):565–574. doi: 10.1007/s15010-016-0889-8
  • Kroten A, Toczylowski K, Oldak E, et al. Toxocarosis in children: poor hygiene habits and contact with dogs is related to longer treatment. Parasitol Res. 2018 May;117(5):1513–1519. doi: 10.1007/s00436-018-5833-7
  • Ma G, Holland CV, Wang T, et al. Human toxocariasis. Lancet Infect Dis. 2018 Jan;18(1):e14–e24. doi: 10.1016/S1473-3099(17)30331-6
  • Horton RJ. Albendazole in treatment of human cystic echinococcosis: 12 years of experience. Acta Trop. 1997 Apr 1;64(1–2):79–93.
  • Horton J. Albendazole: a review of anthelmintic efficacy and safety in humans. Parasitology. 2000;121 Suppl(S1):S113–132. doi: 10.1017/S0031182000007290
  • Choi GY, Yang HW, Cho SH, et al. Acute drug-induced hepatitis caused by albendazole. J Korean Med Sci. 2008 Oct;23(5):903–905. doi: 10.3346/jkms.2008.23.5.903
  • Tas A, Köklü S, Celik H. Loss of body hair as a side effect of albendazole. Wien Klin Wochenschr. 2012 Mar;124(5–6):220. doi: 10.1007/s00508-011-0112-y
  • Marin Zuluaga JI, Marin Castro AE, Perez Cadavid JC, et al. Albendazole-induced granulomatous hepatitis: a case report. J Med Case Rep. 2013 Jul 26;7(1):201. doi: 10.1186/1752-1947-7-201
  • Haynes RK. From artemisinin to new artemisinin antimalarials: biosynthesis, extraction, old and new derivatives, stereochemistry and medicinal chemistry requirements. Curr Top Med Chem. 2006;6(5):509–537. doi: 10.2174/156802606776743129
  • White NJ. The treatment of malaria. N Engl J Med. 1996 Sep 12;335(11):800–806.
  • Bunnag D, Viravan C, Looareesuwan S, et al. Clinical trial of artesunate and artemether on multidrug resistant falciparum malaria in Thailand. A preliminary report. Southeast Asian J Trop Med Public Health. 1991 Sep;22(3):380–385.
  • Adekunle AS, Falade CO, Agbedana EO, et al. Assessment of side effects of administration of artemether in humans. BiolMed. 2009;1(3):15–19.‏.
  • Liu YX, Wu W, Liang YJ, et al. New uses for old drugs: the tale of artemisinin derivatives in the elimination of schistosomiasis japonica in China. Molecules. 2014 Sep 19;19(9):15058–15074.
  • Keiser J, Utzinger J. Artemisinins and synthetic trioxolanes in the treatment of helminth infections. Curr Opin Infect Dis. 2007 Dec;20(6):605–612. doi: 10.1097/QCO.0b013e3282f19ec4
  • Shalaby HA, Abdel-Shafy S, Abdel-Rahman KA, et al. Comparative in vitro effect of artemether and albendazole on adult Toxocara canis. Parasitol Res. 2009 Oct;105(4):967–976. doi: 10.1007/s00436-009-1479-9
  • Derda M, Hadaś E, Cholewiński M, et al. As a plant with potential use in the treatment of acanthamoebiasis. Parasitol Res. 2016 Apr;115(4):1635–1639. doi: 10.1007/s00436-016-4902-z
  • Crespo-Ortiz MP, Wei MQ. Antitumor activity of artemisinin and its derivatives: from a well-known antimalarial agent to a potential anticancer drug. J Biomed Biotechnol. 2012;2012:247597. doi: 10.1155/2012/247597
  • Appalasamy S, Lo KY, Ch’ng SJ, et al. Antimicrobial activity of artemisinin and precursor derived from in vitro plantlets of Artemisia annua L. Biomed Res Int. 2014;2014:215872. doi: 10.1155/2014/215872
  • Shi C, Li H, Yang Y, et al. Anti-inflammatory and immunoregulatory functions of artemisinin and its derivatives. Mediators Inflamm. 2015;2015:435713. doi: 10.1155/2015/435713
  • Li S, Zhao X, Lazarovici P, et al. Artemether Activation of AMPK/GSK3β(ser9)/Nrf2 Signaling Confers Neuroprotection towards β-Amyloid-Induced Neurotoxicity in 3xTg Alzheimer’s Mouse Model. Oxid Med Cell Longev. 2019 Nov 21;2019:1862437. doi: 10.1155/2019/1862437
  • Abou Rayia DM, Saad AE, Ashour DS, et al. Implication of artemisinin nematocidal activity on experimental trichinellosis: In vitro and in vivo studies. Parasitol Int. 2017 Apr;66(2):56–63. doi: 10.1016/j.parint.2016.11.012
  • Nassef NA, El–Kersh WM, El–Nahas NS, et al. Parasitological, histopathological, and immunohistochemical assessment of nitric oxide synthase inhibitor: aminoguanidine versus albendazole in the treatment of experimental murine toxocariasis. Menoufia Med J. 2014;27(1):103.‏. doi: 10.4103/1110-2098.132778
  • Kayes SG, Oaks JA. Effect of inoculum size and length of infection on the distribution of Toxocara canis larvae in the mouse. Am J Trop Med Hyg. 1976 Jul;25(4):573–580. doi: 10.4269/ajtmh.1976.25.573
  • Faz-López B, Ledesma-Soto Y, Romero-Sánchez Y, et al. Signal transducer and activator of transcription factor 6 signaling contributes to control host lung pathology but favors susceptibility against Toxocara canis infection. Biomed Res Int. 2013;2013:696343. doi: 10.1155/2013/696343
  • Tanabe N, McDonough JE, Vasilescu DM, et al. Pathology of idiopathic pulmonary fibrosis assessed by a combination of microcomputed tomography, histology, and immunohistochemistry. Am J Pathol. 2020 Dec;190(12):2427–2435. doi: 10.1016/j.ajpath.2020.09.001
  • Ozawa A, Sakaue M. New decolorization method produces more information from tissue sections stained with hematoxylin and eosin stain and Masson-trichrome stain. Ann Anat. 2020 Jan;227:151431. doi: 10.1016/j.aanat.2019.151431
  • Shi SR, Shi Y, Taylor CR. Antigen retrieval immunohistochemistry: review and future prospects in research and diagnosis over two decades. J Histochem Cytochem. 2011 Jan;59(1):13–32. doi: 10.1369/jhc.2010.957191
  • Reyaz N, Tayyab M, Khan SA, et al. Correlation of glial fibrillary acidic protein (GFAP) with grading of the neuroglial tumours. J Coll Physicians Surg Pak. 2005 Aug;15(8):472–475.
  • Saraswati S, Agrawal SS, Alhaider AA. Ursolic acid inhibits tumor angiogenesis and induces apoptosis through mitochondrial-dependent pathway in Ehrlich ascites carcinoma tumor. Chem Biol Interact. 2013 Nov 25;206(2):153–165.
  • Oh K, Moon HG, Lee DS, et al. Tissue transglutaminase-interleukin-6 axis facilitates peritoneal tumor spreading and metastasis of human ovarian cancer cells. Lab Anim Res. 2015 Dec;31(4):188–197. doi: 10.5625/lar.2015.31.4.188
  • Schoenardie ER, Scaini CJ, Pepe MS, et al. Vertical transmission of Toxocara canis in successive generations of mice. Rev Bras Parasitol Vet. 2013 Oct-Dec;22(4):623–626. doi: 10.1590/S1984-29612013000400030
  • Strube C, Heuer L, Janecek E. Toxocara spp. infections in paratenic hosts. Vet Parasitol. 2013 Apr 15;193(4):375–389.
  • Abo-Shehada MN, Herbert IV. The migration of larval Toxocara canis in mice. II. Post-intestinal migration in primary infections. Vet Parasitol. 1984 Dec;17(1):75–83. doi: 10.1016/0304-4017(84)90066-9
  • Janecek E, Beineke A, Schnieder T, et al. Neurotoxocarosis: marked preference of Toxocara canis for the cerebrum and T. cati for the cerebellum in the paratenic model host mouse. Parasites Vectors. 2014 Apr 22;7(1):194. doi: 10.1186/1756-3305-7-194
  • Lai SC, Chen KM, Chen HC, et al. Induction of matrix metalloproteinase-9 in mice during Toxocara canis larvae migration. Parasitol Res. 2005 Feb;95(3):193–200. doi: 10.1007/s00436-004-1271-9
  • Chou CM, Lee YL, Liao CW, et al. Enhanced expressions of neurodegeneration-associated factors, UPS impairment, and excess Aβ accumulation in the hippocampus of mice with persistent cerebral toxocariasis. Parasites Vectors. 2017 Dec 22;10(1):620. doi: 10.1186/s13071-017-2578-6
  • Holland CV, Hamilton CM. The significance of cerebral toxocariasis: a model system for exploring the link between brain involvement, behaviour and the immune response. J Exp Biol. 2013 Jan 1;216(Pt 1):78–83.
  • Xiao S, Tanner M, N’Goran EK, et al. Recent investigations of artemether, a novel agent for the prevention of schistosomiasis japonica, mansoni and haematobia. Acta Trop. 2002 May;82(2):175–181. doi: 10.1016/S0001-706X(02)00009-8
  • Wang W, Li TY, Ji Y, et al. Efficacy of artemether and artesunate in mice infected with praziquantel non-susceptible isolate of Schistosoma japonicum. Parasitol Res. 2014 Mar;113(3):925–931. doi: 10.1007/s00436-013-3724-5
  • Meshnick SR. Artemisinin antimalarials: mechanisms of action and resistance. Med Trop. 1998 Mar;58(3 Suppl):13–17.
  • Meshnick SR. Artemisinin and its derivatives. In: Rosenthal PJ, editor. Antimalarial chemotherapy. Infectious disease. Totowa, NJ: Humana Press; 2001. doi:10.1007/978-1-59259-111-4_10
  • Bridgford JL, Xie SC, Cobbold SA, et al. Artemisinin kills malaria parasites by damaging proteins and inhibiting the proteasome. Nat Commun. 2018 Aug;9(1):3801. doi: 10.1038/s41467-018-06221-1
  • Liao CW, Fan CK, Kao TC, et al. Brain injury-associated biomarkers of TGF-beta1, S100B, GFAP, NF-L, tTG, AbetaPP, and tau were concomitantly enhanced and the UPS was impaired during acute brain injury caused by Toxocara canis in mice. BMC Infect Dis. 2008 Jun 24;8(1):84. doi: 10.1186/1471-2334-8-84
  • Eid MM, El-Kowrany SI, Othman AA, et al. Immunopathological changes in the brain of immunosuppressed mice experimentally infected with Toxocara canis. Korean J Parasitol. 2015 Feb;53(1):51–58. doi: 10.3347/kjp.2015.53.1.51
  • Springer A, Heuer L, Janecek-Erfurth E, et al. Histopathological characterization of Toxocara canis- and T. cati-induced neurotoxocarosis in the mouse model. Parasitol Res. 2019 Sep;118(9):2591–2600. doi: 10.1007/s00436-019-06395-7
  • Waindok P, Strube C. Neuroinvasion of Toxocara canis- and T. cati-larvae mediates dynamic changes in brain cytokine and chemokine profile. J Neuroinflammation. 2019 Jul 17;16(1):147.
  • Clark RS, Kochanek PM, Watkins SC, et al. Caspase-3 mediated neuronal death after traumatic brain injury in rats. J Neurochem. 2000 Feb;74(2):740–753. doi: 10.1046/j.1471-4159.2000.740740.x
  • D’Amelio M, Sheng M, Cecconi F. Caspase-3 in the central nervous system: beyond apoptosis. Trends Neurosci. 2012 Nov;35(11):700–709. doi: 10.1016/j.tins.2012.06.004
  • Okonkwo DO, Yue JK, Puccio AM, et al. Transforming research and clinical knowledge in traumatic brain injury (TRACK-TBI) investigators. GFAP-BDP as an acute diagnostic marker in traumatic brain injury: results from the prospective transforming research and clinical knowledge in traumatic brain injury study. J Neurotrauma. 2013 Sep 1;30(17):1490–1497.
  • Li YX, Sibon OCM, Dijkers PF. Inhibition of NF-κB in astrocytes is sufficient to delay neurodegeneration induced by proteotoxicity in neurons. J Neuroinflammation. 2018 Sep 11;15(1):261.
  • Vainchtein ID, Molofsky AV. Astrocytes and Microglia: in sickness and in health. Trends Neurosci. 2020 Mar;43(3):144–154. doi: 10.1016/j.tins.2020.01.003
  • Sofroniew MV, Vinters HV. Astrocytes: biology and pathology. Acta Neuropathol. 2010 Jan;119(1):7–35. doi: 10.1007/s00401-009-0619-8
  • Mengying Z, Yiyue X, Tong P, et al. Apoptosis and necroptosis of mouse hippocampal and parenchymal astrocytes, microglia and neurons caused by angiostrongylus cantonensis infection. Parasites Vectors. 2017 Dec 19;10(1):611. doi: 10.1186/s13071-017-2565-y
  • Silver J, Miller JH. Regeneration beyond the glial scar. Nat Rev Neurosci. 2004 Feb;5(2):146–156. doi: 10.1038/nrn1326
  • Kwon HS, Koh SH. Neuroinflammation in neurodegenerative disorders: the roles of microglia and astrocytes. Transl Neurodegener. 2020;9:1–12.‏. doi: 10.1186/s40035-020-00221-2
  • Abbott NJ, Rönnbäck L, Hansson E. Astrocyte-endothelial interactions at the blood-brain barrier. Nat Rev Neurosci. 2006 Jan;7(1):41–53. doi: 10.1038/nrn1824
  • Abdelhak A, Foschi M, Abu-Rumeileh S, et al. Blood GFAP as an emerging biomarker in brain and spinal cord disorders. Nat Rev Neurol. 2022 Mar;18(3):158–172. doi: 10.1038/s41582-021-00616-3
  • Edagha IA, Peter AI, Aquaisua AN. Histopathological effect of Nauclea latifolia ethanolic leaf extract and artemether/lumefantrine on the hippocampus of P berghei–infected mice. Int J Brain Cognitive Sci. 2017;6:9–16.‏.
  • O’Neill LA, Kaltschmidt C. NF-kappa B: a crucial transcription factor for glial and neuronal cell function. Trends Neurosci. 1997 Jun;20(6):252–258. doi: 10.1016/S0166-2236(96)01035-1
  • Mattson MP, Camandola S. NF-kappaB in neuronal plasticity and neurodegenerative disorders. J Clin Invest. 2001 Feb;107(3):247–254. doi: 10.1172/JCI11916
  • Downer EJ, Johnston DG, Lynch MA. Differential role of Dok1 and Dok2 in TLR2-induced inflammatory signaling in glia. Mol Cell Neurosci. 2013 Sep;56:148–158. doi: 10.1016/j.mcn.2013.04.007
  • Elgendy DI, Othman A, Saied E, et al. Assessment of neuroinflammatory and neurodegenerative alterations in the brain in a mouse model of visceral larva migrans. J Egypt Soc Parasitol. 2020;50(3):467–476.‏. doi: 10.21608/jesp.2020.130833
  • Li F, Li XL, Chen SJ, et al. Excretory/Secretory proteins of adult Toxocara canis induce changes in the expression of proteins involved in the NOD1-RIP2-NF-κB pathway and modulate cytokine production in mouse macrophages. Exp Parasitol. 2021 Oct;229:108152.
  • Okorji UP, Velagapudi R, El-Bakoush A, et al. Antimalarial drug artemether inhibits Neuroinflammation in BV2 microglia through Nrf2-dependent mechanisms. Mol Neurobiol. 2016 Nov;53(9):6426–6443. doi: 10.1007/s12035-015-9543-1
  • Ghavami S, Shojaei S, Yeganeh B, et al. Autophagy and apoptosis dysfunction in neurodegenerative disorders. Prog Neurobiol. 2014 Jan;112:24–49.
  • Menzies FM, Fleming A, Rubinsztein DC. Compromised autophagy and neurodegenerative diseases. Nat Rev Neurosci. 2015 Jun;16(6):345–457. doi: 10.1038/nrn3961
  • Porter AG, Jänicke RU. Emerging roles of caspase-3 in apoptosis. Cell Death Differ. 1999 Feb;6(2):99–104. doi: 10.1038/sj.cdd.4400476
  • Beshay EVN, El-Refai SA, Sadek GS, et al. Mesenchymal stem cells combined with albendazole as a novel therapeutic approach for experimental neurotoxocariasis. Parasitology. 2020 Jun;147(7):799–809. doi: 10.1017/S003118202000044X
  • Li S, Peng T, Zhao X, et al. Artemether confers neuroprotection on cerebral ischemic injury through stimulation of the Erk1/2-P90rsk-CREB signaling pathway. Redox Biol. 2021 Oct;46:102069.
  • Resende NM, Gazzinelli-Guimarães PH, Barbosa FS, et al. New insights into the immunopathology of early Toxocara canis infection in mice. Parasites Vectors. 2015 Jul 2;8(1):354.
  • Botros SS, Mahmoud MR, Moussa MM, et al. Immunohistopathological and biochemical changes in Schistosoma mansoni-infected mice treated with artemether. J Infect. 2007 Nov;55(5):470–477. doi: 10.1016/j.jinf.2007.07.022
  • Madbouly NA, Shalash IR, El Deeb SO, et al. Effect of artemether on cytokine profile and egg induced pathology in murine schistosomiasis mansoni. J Adv Res. 2015 Nov;6(6):851–857. doi: 10.1016/j.jare.2014.07.003
  • Demirci C, Gargili A, Kandil A, et al. Inhibition of inducible nitric oxide synthase in murine visceral larva migrans: effects on lung and liver damage. Chin J Physiol. 2006 Dec 31;49(6):326–334.
  • Yarsan E, Ç A, Ayçiçek H, et al. Effects of albendazole treatment on haematological and biochemical parameters in healthy and Toxocara canis infected mice. Turk J Vet Anim Sci. 2003;27(5):1057–1063.‏.
  • Moawad MA, Amin MM, Hafez EN. Role of ionizing radiation on controlling kidney changes in experimental infection with Toxocara canis. AVMJ. 2015;61(147):87–94.‏.
  • Sayiner S, Altaş M, Camkerten G, et al. Kidney tissue selenium levels of Toxocara canis infected mice given Nigella sativa. J VetBio Sci Tech. 2021;6(3):278–283.‏. doi: 10.31797/vetbio.977962
  • Xiao SH, You JQ, Gao HF, et al. Schistosoma japonicum: effect of artemether on glutathione S-transferase and superoxide dismutase. Exp Parasitol. 2002 Sep;102(1):38–45. doi: 10.1016/S0014-4894(02)00145-5
  • El-Bassiouni EA, Helmy MH, Saad EI, et al. Modulation of the antioxidant defence in different developmental stages of Schistosoma mansoni by praziquantel and artemether. Br J Biomed Sci. 2007;64(4):168–174. doi: 10.1080/09674845.2007.11732782
  • El-Lakkany NM, Seif El-Din SH. Haemin enhances the in vivo efficacy of artemether against juvenile and adult Schistosoma mansoni in mice. Parasitol Res. 2013 May;112(5):2005–2015. doi: 10.1007/s00436-013-3358-7
  • Pecinali NR, Gomes RN, Amendoeira FC, et al. Influence of murine Toxocara canis infection on plasma and bronchoalveolar lavage fluid eosinophil numbers and its correlation with cytokine levels. Vet Parasitol. 2005 Nov 25;134(1–2):121–130.
  • Hamilton CM, Brandes S, Holland CV, et al. Cytokine expression in the brains of Toxocara canis-infected mice. Parasite Immunol. 2008 Mar;30(3):181–185. doi: 10.1111/j.1365-3024.2007.01002.x
  • Cheng Y, Li J, Peng J. Study on variable IL–6 and IL–8 levels in the serum of SD rats infected with Toxocara canis. Zhongguo Bingyuan Shengwuxue Zazhi/Journal Of Pathogen Biology. 2010;5(8):601–603.‏.
  • Długosz E, Wasyl K, Klockiewicz M, et al. Toxocara canis mucins among other excretory-secretory antigens induce in vitro secretion of cytokines by mouse splenocytes. Parasitol Res. 2015 Sep;114(9):3365–3371. doi: 10.1007/s00436-015-4561-5
  • Michalopoulos GK. Liver regeneration after partial hepatectomy: critical analysis of mechanistic dilemmas. Am J Pathol. 2010 Jan;176(1):2–13. doi: 10.2353/ajpath.2010.090675
  • Schmidt-Arras D, Rose-John S. IL-6 pathway in the liver: from physiopathology to therapy. J Hepatol. 2016 Jun;64(6):1403–1415. doi: 10.1016/j.jhep.2016.02.004
  • Fu W, Ma Y, Li L, et al. Artemether Regulates Metaflammation to Improve Glycolipid Metabolism in db/db Mice. Diabetes Metab Syndr Obes. 2020 May 19;13:1703–1713. doi:10.2147/DMSO.S240786.
  • Elli L, Bergamini CM, Bardella MT, et al. Transglutaminases in inflammation and fibrosis of the gastrointestinal tract and the liver. Dig Liver Dis. 2009 Aug;41(8):541–550. doi: 10.1016/j.dld.2008.12.095
  • Jeong EM, Son YH, Choi Y, et al. Transglutaminase 2 is dispensable but required for the survival of mice in dextran sulfate sodium-induced colitis. Exp Mol Med. 2016 Nov 4;48(11):e267. doi: 10.1038/emm.2016.95
  • Tatsukawa H, Fukaya Y, Frampton G, et al. Role of transglutaminase 2 in liver injury via cross-linking and silencing of transcription factor Sp1. Gastroenterology. 2009 May;136(5):1783–95.e10. doi: 10.1053/j.gastro.2009.01.007
  • Su T, Qin XY, Furutani Y, et al. Imaging of the ex vivo transglutaminase activity in liver macrophages of sepsis mice. Anal Biochem. 2020 May 15;597:113654.
  • Oh K, Park HB, Byoun OJ, et al. Epithelial transglutaminase 2 is needed for T cell interleukin-17 production and subsequent pulmonary inflammation and fibrosis in bleomycin-treated mice. J Exp Med. 2011 Aug 1;208(8):1707–1719. doi: 10.1084/jem.20101457
  • Kanobana K, Vereecken K, Junco Diaz R, et al. Toxocara seropositivity, atopy and asthma: a study in Cuban schoolchildren. Trop Med Int Health. 2013 Apr;18(4):403–406. doi: 10.1111/tmi.12073
  • Li L, Gao W, Yang X, et al. Asthma and toxocariasis. Ann Allergy Asthma Immunol. 2014 Aug;113(2):187–192. doi: 10.1016/j.anai.2014.05.016
  • Khozime A, Mirsadraee M, Borji H. Toxocara sero-prevalence and its relationship with allergic asthma in asthmatic patients in north-eastern Iran. J Helminthol. 2019 Nov;93(6):677–680. doi: 10.1017/S0022149X1800086X
  • Aghaei S, Riahi SM, Rostami A, et al. Toxocara spp. infection and risk of childhood asthma: a systematic review and meta-analysis. Acta Trop. 2018 Jun;182:298–304.
  • Pinelli E, Brandes S, Dormans J, et al. Infection with the roundworm Toxocara canis leads to exacerbation of experimental allergic airway inflammation. Clin Exp Allergy. 2008 Apr;38(4):649–658. doi: 10.1111/j.1365-2222.2007.02908.x
  • Cheng C, Ho WE, Goh FY, et al. Anti-malarial drug artesunate attenuates experimental allergic asthma via inhibition of the phosphoinositide 3-kinase/Akt pathway. PLoS One. 2011;6(6):e20932. doi: 10.1371/journal.pone.0020932
  • Ho WE, Cheng C, Peh HY, et al. Anti-malarial drug artesunate ameliorates oxidative lung damage in experimental allergic asthma. Free Radic Biol Med. 2012 Aug 1;53(3):498–507. doi: 10.1016/j.freeradbiomed.2012.05.021
  • Wei M, Xie X, Chu X, et al. Dihydroartemisinin suppresses ovalbumin-induced airway inflammation in a mouse allergic asthma model. Immunopharmacol Immunotoxicol. 2013 Jun;35(3):382–389. doi: 10.3109/08923973.2013.785559
  • Luo QZ, Lin JT, Li H, et al. Effects of artesunate on cigarette smoke-induced lung oxidative damage in mice and the expression of Nrf2 and the possible mechanism. Zhonghua Yi Xue Za Zhi. 2016 Mar 29;96(12):960–965.
  • Cao TH, Jin SG, Fei DS, et al. Artesunate Protects Against Sepsis-Induced Lung Injury Via Heme Oxygenase-1 Modulation. Inflammation. 2016 Apr;39(2):651–662. doi: 10.1007/s10753-015-0290-2
  • Wang Y, Huang G, Mo B, et al. Artesunate modulates expression of matrix metalloproteinases and their inhibitors as well as collagen-IV to attenuate pulmonary fibrosis in rats. Genet Mol Res. 2016 Jun 3;15(2). doi: 10.4238/gmr.15027530
  • Wang Y, Wang Y, You F, et al. Novel use for old drugs: the emerging role of artemisinin and its derivatives in fibrosis. Pharmacol Res. 2020 Jul;157:104829.
  • Dolivo D, Weathers P, Dominko T. Artemisinin and artemisinin derivatives as anti-fibrotic therapeutics. Acta Pharm Sin B. 2021 Feb;11(2):322–339. doi: 10.1016/j.apsb.2020.09.001

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.